Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets recall — FDA D-0259-2026
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Overview of recall records associated with Alvogen, Inc, including dates, categories and classifications where available.
Classification mix: Class II: 1, Class I: 1.
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
This page summarizes recall records in which the official source identifies Alvogen, Inc as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.